Improved formulations: Sustained-release peptide formulations reducing injection frequency currently in development
The disease is called pernicious ( deadly ), because before scientists first isolated B12 (after which, shots became available), it was lethal
Users typically experience reductions in waist circumference, improved metabolic markers, more stable energy levels throughout the day, and better exercise performance and recovery
FDA prescribing information, Mounjaro (tirzepatide) injection, BLA 215866: approved indications, once-weekly 2.515 mg titration, ~5-day half-life, boxed warning for thyroid C-cell tumors
Injections can promote healthier and stronger growth of these tissues
doi: 10.4161/pri.4.2.11960 51 DisantoG.AdiutoriR.DobsonR.MartinelliV.Dalla CostaG.RuniaT.et al